Antihypertensive APIs are a class of drugs that act by targeting various mechanisms involved in blood pressure regulation. Protheragen provides a full range of antihypertensive APIs to support global customer research, including but not limited to angiotensin-converting enzyme (ACE) inhibitors, angiotensin II inhibitors, cep receptor blockers (ARB), beta- Receptor blockers, calcium channel blockers (CCB), diuretics, etc.